Covid-19 and autoimmunity

No abstract is available for this paper.

• Publication year

  2020

• Venue

  Autoimmunity Reviews

• Publication date

  2020-06-11

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.autrev.2020.102597PMID 32535093PMCID 7289100
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in Turkey

  2021cited by this paper
• Clinical Characteristics of Coronavirus Disease 2019 in China

  2020cited by this paper
• Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19

  2020cited by this paper
• Imaging Findings in Four COVID-19 Patients.

  2020cited by this paper
• Guillain Barre syndrome associated with COVID-19 infection: A case report

  2020cited by this paper
• On the Alert for Cytokine Storm: Immunopathology in COVID‐19

  2020cited by this paper
• Rheumatic disease and COVID-19: initial data from the COVID-19 Global Rheumatology Alliance provider registries

  2020cited by this paper
• Immune Thrombocytopenic Purpura in a Patient with Covid-19

  2020cited by this paper
• Role of immunosuppressive therapy in rheumatic diseases concurrent with COVID-19

  2020cited by this paper
• On the molecular determinants of the SARS-CoV-2 attack

  2020cited by this paper
• Guillain–Barré Syndrome Associated with SARS-CoV-2

  2020cited by this paper
• Miller Fisher syndrome and polyneuritis cranialis in COVID-19

  2020cited by this paper
• Cytokine release syndrome in severe COVID-19

  2020cited by this paper
• [COVID-19 - 2019].

  2020cited by this paper
• Rituximab for granulomatosis with polyangiitis in the pandemic of covid-19: lessons from a case with severe pneumonia

  2020cited by this paper
• Clinical and Autoimmune Characteristics of Severe and Critical Cases of COVID‐19

  2020cited by this paper
• Lupus anticoagulant is frequent in patients with Covid‐19

  2020cited by this paper
• High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study

  2020cited by this paper
• Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine

  2020cited by this paper
• COVID-19 Complicated by Acute Pulmonary Embolism

  2020cited by this paper
• Incidence and Clinical Course of COVID-19 in Patients with Connective Tissue Diseases: A Descriptive Observational Analysis

  2020cited by this paper
• Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young

  2020cited by this paper
• Impact of COVID-19 pandemic on patients with large-vessel vasculitis in Italy: a monocentric survey

  2020cited by this paper
• What Does the COVID-19 Pandemic Mean for Rheumatology Patients?

  2020cited by this paper
• COVID-19-induced acute respiratory failure: an exacerbation of organ-specific autoimmunity?

  2020cited by this paper
• Covid-19 in Immune-Mediated Inflammatory Diseases — Case Series from New York

  2020cited by this paper
• Systemic sclerosis and the COVID-19 pandemic: World Scleroderma Foundation preliminary advice for patient management

  2020cited by this paper
• Effective treatment of severe COVID-19 patients with tocilizumab

  2020cited by this paper
• American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID‐19 Pandemic: Version 1

  2020cited by this paper
• The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease

  2020cited by this paper
• Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions

  2020cited by this paper
• Continuous hydroxychloroquine or colchicine therapy does not prevent infection with SARS-CoV-2: Insights from a large healthcare database analysis

  2020cited by this paper
• Novel COronaVirus Disease 2019 (COVID-19) epidemic: What are the risks for systemic sclerosis patients?

  2020cited by this paper
• Why judiciously timed anti-IL 6 therapy may be of benefit in severe COVID-19 infection

  2020cited by this paper
• SARS-CoV-2 infection among patients with systemic autoimmune diseases

  2020cited by this paper
• COVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome?

  2020cited by this paper
• Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19

  2020cited by this paper
• The immune system of children: the key to understanding SARS-CoV-2 susceptibility?

  2020cited by this paper
• Hyperinflammatory shock in children during COVID-19 pandemic

  2020cited by this paper
• Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy

  2020cited by this paper
• Cytokine storm syndrome in severe COVID-19

  2020cited by this paper
• Immunomodulatory therapy for the management of severe COVID-19. Beyond the anti-viral therapy: A comprehensive review

  2020cited by this paper
• Targeting the inflammatory cascade with anakinra in moderate to severe COVID-19 pneumonia: case series

  2020cited by this paper
• Clinical Characterization of 162 COVID-19 patients in Israel: Preliminary Report from a Large Tertiary Center.

  2020cited by this paper
• Clinical Insights and Management Recommendations for COVID-19 Patients Hospitalized in Internal Medicine Departments: Recommendations by the Corona Department Heads in Israel.

  2020cited by this paper
• The Urgency of Care during the Covid-19 Pandemic — Learning as We Go

  2020cited by this paper
• Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19

  2020cited by this paper
• Hydroxychloroquine in Patients with Rheumatic Disease Complicated by COVID-19: Clarifying Target Exposures and the Need for Clinical Trials

  2020cited by this paper
• Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State

  2020cited by this paper
• An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study

  2020cited by this paper
• COVID-19 infection in a northern-Italian cohort of systemic lupus erythematosus assessed by telemedicine

  2020cited by this paper
• COVID-19 with rheumatic diseases: a report of 5 cases

  2020cited by this paper
• COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs

  2020cited by this paper
• Should Clinicians Use Chloroquine or Hydroxychloroquine Alone or in Combination With Azithromycin for the Prophylaxis or Treatment of COVID-19? Living Practice Points From the American College of Physicians (Version 1)

  2020cited by this paper
• Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study

  2020cited by this paper
• Response to: ‘Correspondence on ‘Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus under long-term treatment with hydroxychloroquine’’ by Nikpour et al

  2020cited by this paper
• Incidence of COVID‐19 in Patients With Rheumatic Diseases Treated With Targeted Immunosuppressive Drugs: What Can We Learn From Observational Data?

  2020cited by this paper
• Molecular mimicry may explain multi-organ damage in COVID-19

  2020cited by this paper
• Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study

  2020cited by this paper
• Immune Thrombocytopenia (ITP) in a Pediatric Patient Positive for SARS-CoV-2

  2020cited by this paper
• Issues of pathology of a new coronavirus infection CoVID-19

  2020cited by this paper
• Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

  2020cited by this paper
• Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro

  2020cited by this paper
• Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.

  2020cited by this paper
• Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases

  2020cited by this paper
• Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

  2020cited by this paper
• Clinical Features of 69 Cases with Coronavirus Disease 2019 in Wuhan, China

  2020cited by this paper
• Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis

  2020cited by this paper
• Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro

  2020cited by this paper
• Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence

  2020cited by this paper
• COVID-19 infection and rheumatoid arthritis: Faraway, so close!

  2020cited by this paper
• Are my patients with rheumatic diseases at higher risk of COVID-19?

  2020cited by this paper
• Could Sars-coronavirus-2 trigger autoimmune and/or autoinflammatory mechanisms in genetically predisposed subjects?

  2020cited by this paper
• COVID‐19 epidemic: Disease characteristics in children

  2020cited by this paper
• Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence?

  2020cited by this paper
• Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies

  2020cited by this paper
• COVID-19 in a patient with systemic sclerosis treated with tocilizumab for SSc-ILD

  2020cited by this paper
• What is the role of rheumatologists in the era of COVID-19?

  2020cited by this paper
• COVID-19 and Kawasaki Disease: Novel Virus and Novel Case.

  2020cited by this paper
• Middle East respiratory syndrome coronavirus (MERS-CoV): A review.

  2019cited by this paper
• The role of viral infections in the development of autoimmune diseases

  2019cited by this paper
• B Cells and Antibodies in Kawasaki Disease

  2019cited by this paper
• Kawasaki disease shock syndrome: clinical characteristics and possible use of IL-6, IL-10 and IFN-γ as biomarkers for early recognition

  2019cited by this paper
• Antiphospholipid Antibodies and Their Relationship With Infections, Vaccines, and Drugs

  2017cited by this paper
• Diagnosis of Systemic Capillary Leak Syndrome in a Young Child Treated with Intravenous Immunoglobulin in the Acute Phase

  2017influential reference
• Catastrophic antiphospholipid syndrome: an update.

  2017cited by this paper
• Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association

  2017cited by this paper
• Antiphospholipid Syndrome

  2017cited by this paper
• Infections as a cause of autoimmune rheumatic diseases

  2016cited by this paper
• Viruses, anti-viral therapy, and viral vaccines in children with immune thrombocytopenia.

  2016cited by this paper
• Antiphospholipid syndrome.

  2016influential reference
• Environmental Basis of Autoimmunity

  2016cited by this paper
• 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis

  2016cited by this paper
• From HBV to HPV: Designing vaccines for extensive and intensive vaccination campaigns worldwide.

  2016cited by this paper
• Describing Kawasaki shock syndrome: results from a retrospective study and literature review

  2016cited by this paper
• [THE ENVIRONMENT AND AUTOIMMUNE DISEASES].

  2015cited by this paper
• Understanding toxic shock syndrome

  2015cited by this paper
• Clinical Characterization of Antiphospholipid Syndrome by Detection of IgG Antibodies Against β2‐Glycoprotein I Domain 1 and Domain 4/5: Ratio of Anti–Domain 1 to Anti–Domain 4/5 As a Useful New Biomarker for Antiphospholipid Syndrome

  2015cited by this paper
• Antiphospholipid antibody syndrome: From bench to bedside

  2015cited by this paper
• Antiphospholipid syndrome: antibodies to Domain 1 of β2‐glycoprotein 1 correctly classify patients at risk

  2015influential reference

• Prolonged remission of dermatomyositis and autoantibody negativization following SARS-CoV-2 infection in an elderly patient.

  2026cites this paper
• Plasmablast Storms: Microbial Drivers of Acute and Chronic Autoimmune Flares

  2026cites this paper
• Identification of Putative Serum Autoantibodies Associated with Post-Acute Sequelae of COVID-19 via Comprehensive Protein Array Analysis

  2025cites this paper
• Study on the dynamic changes in antinuclear antibody spectrum in SARS-CoV-2 infection: a retrospective analysis

  2025cites this paper
• РАДІОЛОГІЧНО-МОРФОЛОГІЧНЕ СПІВСТАВЛЕННЯ ОЗНАК ПАТОЛОГІЧНО ЗМІНЕНИХ ДІЛЯНОК ЛЕГЕНЕВОЇ ТКАНИНИ ПРИ КОРОНАВІРУСНІЙ ХВОРОБІ-2019

  2025cites this paper
• COVID-19 related epigenetic changes and atopic dermatitis: An exploratory analysis

  2025cites this paper
• Detection of autoantibodies in severe COVID-19 patients two years after hospital discharge

  2025cites this paper
• COVID-19 Vaccination and Acute Anterior Uveitis—A Case Control Study

  2025cites this paper
• Genes Encoding Heat Shock Proteins Are Associated with Risk and Clinical Course of Severe COVID-19: A Pilot Study

  2025cites this paper
• SARS-CoV-2-induced sensory perturbations: A narrative review of clinical phenotypes, molecular pathologies, and possible interventions

  2025cites this paper
• Unravelling the Risk of Autoimmune Diseases After SARS-CoV-2 Infection: A Meta-analysis

  2025cites this paper
• Long-Term Effects of COVID-19 on Women’s Reproductive Health and Its Association with Autoimmune Diseases, Including Multiple Sclerosis

  2025cites this paper
• Longitudinal proteomic and autoantibody signatures after mRNA vaccination in healthy individuals.

  2025cites this paper
• Pediatric autoimmune diseases in the light of COVID-19 pandemic, A retrospective observational big data study

  2025influential citation
• NETosis: A key player in autoimmunity, COVID-19, and long COVID

  2025cites this paper
• Autoimmune hepatitis under the COVID-19 veil: an analysis of the nature of potential associations

  2025cites this paper
• Biological mechanisms of pulmonary inflammation and its association with seropositive rheumatoid arthritis

  2025cites this paper
• Inflammatory tropism in COVID-19: a comparative analysis of Delta and Omicron variants

  2025cites this paper
• Dynamic changes in platelet counts and psychological state in ITP patients after COVID-19 infection

  2025cites this paper
• Pulmonary and Immune Dysfunction in Pediatric Long COVID: A Case Study Evaluating the Utility of ChatGPT-4 for Analyzing Scientific Articles

  2025cites this paper
• Severity-dependent IgG epitope profiling in COVID-19 reveals differential recognition of pathogen-derived antigens

  2025cites this paper
• Severe COVID-19 in Patients with Immune-Mediated Rheumatic Disorders: A Case-Control Study

  2025cites this paper
• Some parallels between chronic fatigue syndrome and post-COVID syndrome: The role of immune dysregulation

  2025cites this paper
• SARS-CoV-2 Spike Protein and Long COVID—Part 1: Impact of Spike Protein in Pathophysiological Mechanisms of Long COVID Syndrome

  2025cites this paper
• Autoantibodies in COVID‐19 convalescent plasma donors

  2025cites this paper
• SARS-CoV-2 Spike Protein and Molecular Mimicry: An Immunoinformatic Screen for Cross-Reactive Autoantigen Candidates

  2025cites this paper
• The relationship between SARS-CoV-2 infection and type 1 diabetes mellitus

  2024cites this paper
• Harnessing Immunomodulatory Polymers for Treatment of Autoimmunity, Allergy, and Transplant Rejection.

  2024cites this paper
• Enfermedad tiroidea posterior a vacunación contra SARS-COV-2

  2024cites this paper
• Angiotensin-Converting Enzyme-2 (ACE2) Downregulation During Coronavirus Infection

  2024cites this paper
• Polyposis of gastrointestinal tract after COVID-19 mRNA vaccination: a report of two cases

  2024cites this paper
• The Onset of Antinuclear Antibodies (ANAs) as a Potential Risk Factor for Mortality and Morbidity in COVID-19 Patients: A Single-Center Retrospective Study

  2024cites this paper
• Autoantibodies in COVID‐19 and Other Viral Diseases: Molecular, Cellular, and Clinical Perspectives

  2024cites this paper
• Onset of acute severe autoimmune hepatitis after severe acute respiratory syndrome coronavirus 2 infection: a case report

  2024cites this paper
• Kinome and phosphoproteome reprogramming underlies the aberrant immune responses in critically ill COVID-19 patients

  2024cites this paper
• Nanomaterials-based electrochemical biosensors for diagnosis of COVID-19.

  2024cites this paper
• Autoantibody profiles assessment in individuals with persistent olfactory impairment following SARS-CoV-2 infection.

  2024cites this paper
• New Onset of Neuro-Sjögren's Syndrome Nine Months After the Third COVID-19 Vaccine Dose: A Case Report

  2024cites this paper
• Therapeutic Potential of Propolis Extract in Managing Hyperinflammation and Long COVID‐19: A Bioinformatics Study

  2024cites this paper
• Global trend analysis, mechanistic insights and future directions of autoimmune ear diseases: Based on comprehensive findings over the past 20 years.

  2024cites this paper
• Evidence for Molecular Mimicry between SARS-CoV-2 and Human Antigens: Implications for Autoimmunity in COVID-19

  2024cites this paper
• Asymptomatic COVID-19 and structural changes in the brain

  2024cites this paper
• Premature Ovarian Insufficiency After Coronavirus Disease 2019 (COVID-19)

  2024cites this paper
• From Viral Infection to Autoimmune Reaction: Exploring the Link between Human Herpesvirus 6 and Autoimmune Diseases

  2024cites this paper
• MMPred: a tool to predict peptide mimicry events in MHC class II recognition

  2024cites this paper
• Increased incidence of Graves’ disease during the COVID-19 pandemic in children and adolescents in the United States

  2024cites this paper
• Change in Pattern of Head and Neck Lesions Diagnosed by FNAC in the Post-COVID-19 Period: Are Lymphoproliferative Disorders on the Rise?

  2024cites this paper
• “Mechanic’s Hand” with Polyarthralgia and Transient Autoimmune Features after COVID Vaccination

  2024cites this paper
• Divergent autoantibody and cytokine levels in COVID‐19 sepsis patients influence survival

  2024cites this paper
• Identification of shared pathogenetic mechanisms between COVID-19 and IC through bioinformatics and system biology

  2024cites this paper
• Long COVID Definition, Symptoms, Risk Factors, Epidemiology and Autoimmunity: A Narrative Review

  2024cites this paper
• Autoimmune hepatitis: Brighton Collaboration case definition and guidelines for data collection, analysis, and presentation of immunisation safety data.

  2024cites this paper
• Self-DNA driven inflammation in COVID-19 and after mRNA-based vaccination: lessons for non-COVID-19 pathologies

  2024cites this paper
• Viruses and thrombocytopenia

  2024cites this paper
• Clinical and immunologic abnormalities in COVID-19

  2024cites this paper
• Risk factors for severe COVID-19 infection and the impact of COVID-19 infection on disease progression among patients with AAV

  2024cites this paper
• No COVID‐19 pandemic impact on incidence and clinical presentation of celiac disease in Italian children

  2024cites this paper
• Autoimmune hepatitis after COVID-19 infection.

  2024cites this paper
• “Mechanics hand” as vaccine related adverse event after COVID-19 vaccination

  2024cites this paper
• Cytokine Signatures and Immune Dysregulation in COVID-19 Patients: Transcriptomic and Serum Analysis

  2024cites this paper
• A case of microscopic polyangiitis with interstitial pneumonia after coronavirus disease-2019 infection, evidenced by positivity for multiple autoantibodies

  2024cites this paper
• Post-COVID syndrome: rheumatological aspects

  2023cites this paper
• Evaluation of Complement Level, Serum Electrophoretic Panel, and Anti-glomerular Basement Membrane in Coronavirus Disease 2019: Focus on Likelihood of Hypersensitivity Type III

  2023cites this paper
• Post-COVID-19 Condition in Military Personnel.

  2023cites this paper
• Hematological Complications in a COVID-19 Patient: A Case Report

  2023cites this paper
• mRNA COVID-19 vaccine elicits potent adaptive immune response without the acute inflammation of SARS-CoV-2 infection

  2023cites this paper
• New sights of low dose IL‐2: Restoration of immune homeostasis for viral infection

  2023cites this paper
• Autoimmune Hemolytic Anemia Associated with COVID-19 Infection in a Patient with High Cardio-metabolic Risk.

  2023cites this paper
• Autoimmune response after SARS-CoV-2 infection and SARS-CoV-2 vaccines.

  2023cites this paper
• Desmoglein-2 and COVID-19 complications: insights into its role as a biomarker, pathogenesis and clinical implications.

  2023cites this paper
• Intrinsic factors behind long‐COVID: II. SARS‐CoV‐2, extracellular vesicles, and neurological disorders

  2023cites this paper
• Anti-phospholipid autoantibodies in human diseases.

  2023cites this paper
• Can Electromagnetic Fields Modulate Inflammation and Cell Death by Acting on the Immune System?

  2023cites this paper
• Enhancing Medical Image Segmentation: Optimizing Cross-Entropy Weights and Post-Processing with Autoencoders

  2023cites this paper
• Autoimmune hepatitis following mRNA COVID-19 vaccine.

  2023cites this paper
• Reccurent guillain barré syndrome after COVID-19

  2023cites this paper
• Mild‐to‐moderate COVID‐19 does not predispose to the development of autoimmune rheumatic diseases or autoimmune‐based thrombosis

  2023cites this paper
• МОЖЕТ ЛИ ДИСФУНКЦИЯ КЛЕТОЧНОГО ИММУНИТЕТА РАССМАТРИВАТЬСЯ КАК ПРИЗНАК ПОСТКОВИДНОГО СИНДРОМА? Асфандиярова

  2023cites this paper
• COVID‐19‐induced autoimmune thyroiditis: Exploring molecular mechanisms

  2023cites this paper
• May be dysfunction of cellular immunity considered a sign of post-COVID syndrome?

  2023cites this paper
• Role of Janus Kinase inhibitors in the management of pulmonary involvement due to Long COVID-19 disease: A case control study

  2023cites this paper
• Impact of COVID-19 vaccination in patients with auto-immune diseases – A nationwide survey from 842 autoimmune patients

  2023cites this paper
• The Effect of COVID-19 Severity, Associated Serum Autoantibodies and Time Interval after the Disease on the Outcomes of Fresh Oocyte ART Cycles in Non-Vaccinated Patients

  2023cites this paper
• Relación entre COVID-19 con el desarrollo de enfermedades autoinmunes

  2023influential citation
• Myosin 16 mimicries may explain post-COVID-19 related neurological consequences

  2023cites this paper
• Antibody responses following the surge of SARS-CoV-2 Omicron infection among patients with systemic autoimmune rheumatic diseases

  2023cites this paper
• Long COVID-19 and Insulin Autoimmune Syndrome: A Case Report.

  2023cites this paper
• Leitlinie S1 für das Management postviraler Zustände am Beispiel Post-COVID-19

  2023cites this paper
• Efficient Representation Learning for Healthcare with Cross-Architectural Self-Supervision

  2023cites this paper
• Severe COVID-19 patients exhibit elevated levels of autoantibodies targeting cardiolipin and platelet glycoprotein with age: a systems biology approach

  2023cites this paper
• Ocular manifestations following COVID-19 vaccination

  2023cites this paper
• Autoimmune bullous disorder flares following severe acute respiratory syndrome coronavirus 2 vaccination: a case series

  2023cites this paper
• Thyroid Autoimmunity and SARS-CoV-2 Infection

  2023cites this paper
• 425. Characterization and predictive risk scoring of long COVID in a South Indian cohort after breakthrough COVID infection; a prospective single centre study

  2023cites this paper
• Expert Consensus: Main Risk Factors for Poor Prognosis in COVID-19 and the Implications for Targeted Measures against SARS-CoV-2

  2023cites this paper
• Long COVID and its cardiovascular consequences: What is known?

  2023cites this paper
• COVID-19 Vaccination and Immunosuppressive Therapy in Immune-Mediated Inflammatory Diseases

  2023cites this paper
• Long COVID or Post-COVID-19 Condition: Past, Present and Future Research Directions

  2023cites this paper
• Spotlight on contributory role of host immunogenetic profiling in SARS-CoV-2 infection: Susceptibility, severity, mortality, and vaccine effectiveness.

  2023cites this paper
• Pharmacological Proposal Approach to Managing Chronic Pain Associated with COVID-19

  2023cites this paper